India to Iraq: Gatifloxacin Export Trade Route
India has recorded 7 verified shipments of Gatifloxacin exported to Iraq, representing a combined trade value of $382.5K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $54.6K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 64% of total export value with 4 shipments worth $242.9K USD. On the buying side, SHAMS AL-THURAYA CO FOR GENERAL is the largest importer in Iraq with $106.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Iraq Gatifloxacin corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $382.5K USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's gatifloxacin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $54.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with gatifloxacin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #18 among India's top gatifloxacin export destinations globally.
On the import side, key buyers of Indian gatifloxacin in Iraq include SHAMS AL-THURAYA CO FOR GENERAL, HAWKARY PHARMACEUITCAL CO.*, SHAMS AL-THURAYA CO FOR GENERAL TRA and 2 others. SHAMS AL-THURAYA CO FOR GENERAL is the single largest importer with 1 shipments valued at $106.7K USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ2
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#18
- Annual growth+22.8%
- Demand growth+21.2%
- Regulatory ease90/100
Top 10 Indian Gatifloxacin Exporters to Iraq
Showing top 10 of 2 Indian suppliers exporting Gatifloxacin to Iraq, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AJANTA PHARMA LIMITED Avg $60.7K per shipment | 4 | $242.9K | 63.5% |
| 2 | AJANTA PHARMA LIMITED Avg $46.5K per shipment | 3 | $139.6K | 36.5% |
This table shows the top 10 of 2 Indian companies exporting gatifloxacin to Iraq, ranked by total trade value. The listed exporters are: AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED . AJANTA PHARMA LIMITED is the dominant supplier with 4 shipments worth $242.9K USD, giving it a 64% market share.
Top 10 Gatifloxacin Importers in Iraq
Showing top 10 of 5 known buyers in Iraq receiving Gatifloxacin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gatifloxacin in Iraq include SHAMS AL-THURAYA CO FOR GENERAL, HAWKARY PHARMACEUITCAL CO.*, SHAMS AL-THURAYA CO FOR GENERAL TRA , SHAMS AL-THURAYA CO FOR , HAWKARY PHARMACEUITCAL CO. The largest importer is SHAMS AL-THURAYA CO FOR GENERAL, accounting for $106.7K USD across 1 shipments — representing 28% of all gatifloxacin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SHAMS AL-THURAYA CO FOR GENERAL | 1 | $106.7K | 27.9% |
| 2 | HAWKARY PHARMACEUITCAL CO.* | 2 | $101.3K | 26.5% |
| 3 | SHAMS AL-THURAYA CO FOR GENERAL TRA | 2 | $92.1K | 24.1% |
| 4 | SHAMS AL-THURAYA CO FOR | 1 | $47.5K | 12.4% |
| 5 | HAWKARY PHARMACEUITCAL CO | 1 | $34.8K | 9.1% |
Top 10 Gatifloxacin Formulations Imported by Iraq
Showing top 10 of 6 product formulations shipped on the India to Iraq Gatifloxacin route, ranked by trade value
Iraq imports a wide range of gatifloxacin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GATE DX (BAK FREE)(GATIFLOXACIN AND DEXAMETHASONE EYE DROPS 0.3%/0.1% W/V) [37100X1= 37100 PACKS]COMPOSITION AS PER INV — accounts for $106.7K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GATE DX (BAK FREE)(GATIFLOXACIN AND DEXAMETHASONE EYE DROPS 0.3%/0.1% W/V) [37100X1= 37100 PACKS]COMPOSITION AS PER INV | 1 | $106.7K | 27.9% |
| 2 | GATE DX (BAK FREE)(GATIFLOXACIN AND DEXA | 2 | $92.1K | 24.1% |
| 3 | GATE EYE DROPS 5ML[35800 X 1 = 35800 PACKS] (GATIFLOXACIN EYE DROPS 0.3% W/V) | 1 | $65.7K | 17.2% |
| 4 | GATE DX (BAK FREE) (GATIFLOXACIN & DEXAM | 1 | $47.5K | 12.4% |
| 5 | GATE EYE DROPS 5ML[18875 X 1 = 18875 VIALS][GATIFLOXACIN EYE DROPS 0.3 % W/V][EACH ML CONTAINS :AS PER INVOICENOS | 1 | $35.6K | 9.3% |
| 6 | GATE EYE DROPS 5ML[18750x1= 18750 VIALS][GATIFLOXACIN EYE DROPS 0.3 % W/V][EACHML CONT:GATIFLOXACIN AS PER INV | 1 | $34.8K | 9.1% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 2 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's gatifloxacin exports to Iraq are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $54.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as gate dx (bak free)(gatifloxacin and dexa and gate eye drops 5ml[35800 x 1 = 35800 packs] (gatifloxacin eye drops 0.3% w/v), suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SHAMS AL-THURAYA CO FOR GENERAL is the largest importer with 1 shipments worth $106.7K USD — representing 28% of all gatifloxacin imports from India on this route.
Route Statistics
- Trade Volume
- $382.5K
- Avg. Shipment
- $54.6K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~26 days
- Annual Growth
- +22.8%
Related Analysis
Other Gatifloxacin Routes
Unlock the Full India to Iraq Gatifloxacin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — India to Iraq Gatifloxacin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gatifloxacin to Iraq?
The leading Indian exporters of Gatifloxacin to Iraq are AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED . AJANTA PHARMA LIMITED holds the largest market share at approximately 64% of total trade value on this route.
Q What is the total value of Gatifloxacin exports from India to Iraq?
India exports Gatifloxacin to Iraq worth approximately $382.5K USD across 7 recorded shipments. The average value per shipment is $54.6K USD.
Q Which ports does India use to ship Gatifloxacin to Iraq?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 2 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to Iraq for Gatifloxacin?
The average transit time for Gatifloxacin shipments from India to Iraq is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Iraq Gatifloxacin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.8% with demand growth tracking at 21.2%. The route is ranked #18 among India's top Gatifloxacin export destinations globally.
Q How many suppliers are active on the India to Iraq Gatifloxacin route?
There are currently 2 active Indian suppliers exporting Gatifloxacin to Iraq. The market is moderately concentrated with AJANTA PHARMA LIMITED accounting for 64% of total shipment value.
Q Who are the main importers of Gatifloxacin from India in Iraq?
The leading importers of Indian Gatifloxacin in Iraq include SHAMS AL-THURAYA CO FOR GENERAL, HAWKARY PHARMACEUITCAL CO.*, SHAMS AL-THURAYA CO FOR GENERAL TRA , SHAMS AL-THURAYA CO FOR , HAWKARY PHARMACEUITCAL CO. SHAMS AL-THURAYA CO FOR GENERAL is the largest buyer with 1 shipments worth $106.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Iraq export trade corridor identified from Indian Customs (DGFT) records for Gatifloxacin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Iraq matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists